Literature DB >> 25671269

High-cost generic drugs--implications for patients and policymakers.

Aaron S Kesselheim, Jonathan D Alpern, William M Stauffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25671269     DOI： 10.1056/NEJMc1415471

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Generic Drugs in the United States: Policies to Address Pricing and Competition.

Authors:  Ravi Gupta; Nilay D Shah; Joseph S Ross
Journal:  Clin Pharmacol Ther       Date:  2019-01-10       Impact factor: 6.875

Review 2.  Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.

Authors:  Toon van der Gronde; Carin A Uyl-de Groot; Toine Pieters
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

3.  Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate.

Authors:  Jeewon Park; SeungJin Bae; Tae-Jin Lee; Kyung-Bok Son
Journal:  Front Pharmacol       Date:  2020-03-06       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.